|
1
|
Luo JW, Wang X, Yang Y and Mao Q: Role of
micro-RNA (miRNA) in pathogenesis of glioblastoma. Eur Rev Med
Pharmacol Sci. 19:1630–1639. 2015.PubMed/NCBI
|
|
2
|
Rachet B, Mitry E, Quinn MJ, Cooper N and
Coleman MP: Survival from brain tumours in England and Wales up to
2001. Br J Cancer. 99:(Suppl 1). S98–S101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cho DY, Lin SZ, Yang WK, Lee HC, Hsu DM,
Lin HL, Chen CC, Liu CL, Lee WY and Ho LH: Targeting cancer stem
cells for treatment of glioblastoma multiforme. Cell Transplant.
22:731–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li
Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem
cell-like glioma cells promote tumor angiogenesis through vascular
endothelial growth factor. Cancer Res. 66:7843–7848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
7
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji J, Black KL and Yu JS: Glioma stem cell
research for the development of immunotherapy. Neurosurg Clin N Am.
21:159–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H,
Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene
expression and chemoresistance of CD133+ cancer stem
cells in glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S
and Sarkar FH: Cross-talk between miRNA and Notch signaling
pathways in tumor development and progression. Cancer Lett.
292:141–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bier A, Giladi N, Kronfeld N, Lee HK,
Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S,
et al: MicroRNA-137 is downregulated in glioblastoma and inhibits
the stemness of glioma stem cells by targeting RTVP-1. Oncotarget.
4:665–676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong JW: MicroRNA-induced silencing of
glioma progression. J Neurosci. 30:3868–3869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu N, Xiao L, Zhao X, Zhao J, Wang J, Wang
F, Cao S and Lin X: miR-125b regulates the proliferation of
glioblastoma stem cells by targeting E2F2. FEBS Lett.
586:3831–3839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu
X, Xiao P, Shi H, Wang R, Chen L, et al: miR-141 is A key regulator
of renal cell carcinoma proliferation and metastasis by controlling
EphA2 expression. Clin Cancer Res. 20:2617–2630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guessous F, Alvarado-Velez M,
Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J,
Schiff D, Purow B and Abounader R: Oncogenic effects of miR-10b in
glioblastoma stem cells. J Neurooncol. 112:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO reports.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
World Medical Association Declaration of
Helsinki: Ethical principles for medical research involving human
subjects. JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clement T, Salone V and Rederstorff M:
Dual luciferase gene reporter assays to study miRNA function.
Methods Mol Biol. 1296:187–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Spinner NB, Colliton RP, Crosnier C,
Krantz ID, Hadchouel M and Meunier-Rotival M: Jagged1 mutations in
alagille syndrome. Hum Mut. 17:18–33. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Stoeck A, Lee SJ, Shih Ie M, Wang
MM and Wang TL: Jagged1 expression regulated by Notch3 and
Wnt/b-catenin signaling pathways in ovarian cancer. Oncotarget.
1:210–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu XX, Wang CH, You N, Chen BJ, Wang XF,
Chen YP and Lin ZX: High Jagged1 expression is associated with poor
outcome in primary glioblastoma. Med Oncol. 32:3412015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vallejo DM, Caparros E and Dominguez M:
Targeting Notch signalling by the conserved miR-8/200 microRNA
family in development and cancer cells. EMBO J. 30:756–769. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Farnie G, Clarke RB, Spence K, Pinnock N,
Brennan K, Anderson NG and Bundred NJ: Novel cell culture technique
for primary ductal carcinoma in situ: Role of Notch and epidermal
growth factor receptor signaling pathways. J Natl Cancer Inst.
99:616–627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan X, Khaki L, Zhu TS, Soules ME, Talsma
CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, et al: NOTCH pathway
blockade depletes CD133-positive glioblastoma cells and inhibits
growth of tumor neurospheres and xenografts. Stem Cells. 28:5–16.
2010.PubMed/NCBI
|
|
28
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial-mesenchymal transition: Concepts and molecular
links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
